Palomino Laboratories (PALX) Cash from Financing Activities (2023 - 2025)

Palomino Laboratories has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $6.5 million for Q3 2025.

• In Q3 2025, Cash from Financing Activities rose 32243.89% year-over-year to $6.5 million; the TTM figure through Sep 2025 stood at $8.3 million (changed N/A YoY), while the FY2024 annual figure was $195437.0, up 146.58% from the prior year.
• Cash from Financing Activities came in at $6.5 million for Q3 2025 at Palomino Laboratories, up from $1.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $6.5 million in Q3 2025 to a low of $20.0 in Q1 2025.
• Average Cash from Financing Activities over 3 years is $1.4 million, with a median of $100759.5 recorded in 2023.
• Year-over-year, Cash from Financing Activities soared 155.0% in 2024 and surged 32243.89% in 2025.
• Over 3 years, Cash from Financing Activities stood at $56766.0 in 2023, then soared by 155.0% to $144753.0 in 2024, then jumped by 4378.45% to $6.5 million in 2025.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $6.5 million in Q3 2025, $1.7 million in Q2 2025, and $20.0 in Q1 2025.